摘要
背景:绝经后骨质疏松的发病与雌激素水平的下降关系密切。目的:观察不同浓度雌激素对小鼠骨髓间充质干细胞成骨分化能力的影响,及其与微小RNA-26a的关系。方法:取小鼠股骨与胫骨骨髓,全骨髓贴壁法获得并纯化骨髓间充质干细胞,分别以0,10-10,10-9,10-8,10-7,10-6 mol/L的雌二醇对其成骨诱导过程进行干预。结果与结论:雌二醇对骨髓间充质干细胞的增殖能力影响不明显,但可明显提高其成骨能力;同时雌二醇可促进骨髓间充质干细胞成骨基因RUNX2,OCN mRNA及RUNX2,SP7蛋白的表达,以10-9 mol/L雌二醇的作用最明显,但10-9mol/L雌二醇促进微小RNA-26a mRNA表达的能力最弱。说明雌二醇可剂量依赖性促进骨髓间充质干细胞的成骨分化,微小RNA-26a可能在此过程中发挥作用。
BACKGROUND: The pathogenesis of postmenopausal osteoporosis and estrogen deficiency is closely related. OBJECTIVE: To investigate the effects of different concentrations of estrogen on osteogenic differentiation of mouse bone marrow mesenchymal stem cells (BMSCs) and the relationship with miRNA-26a. METHODS: Mouse femoral and tibial bone marrow was taken and BMSCs were isolated and purified by the whole bone marrow adherence method. Estrogen at different concentrations (0, 10-10, 10-9, 10-8, 10-7, 10-6 mol/L) was used for osteogenic induction. RESULTS AND CONCLUSION: Estrogen did not greatly influence the proliferation of BMSCs, but it could significantly enhance the osteogenic differentiation capability of BMSCs. At the same time, estrogen, in particular at a concentration of 10-9 mol/L, could promote RUNX2, OCN mRNA and RUNCX2, SP7 protein expression in BMSCs. However, 10-9 mol/L estrogen promoted miRNA-26a mRNA expression at the weakest capability. These findings suggest that estrogen can promote osteogenic differentiation of BMSCs in a dose-dependent manner, and microRNA-26a possibly exerts effects during this process.
出处
《中国组织工程研究》
CAS
CSCD
2012年第19期3433-3437,共5页
Chinese Journal of Tissue Engineering Research